Effects of adlay on azoxymethane-induced colon carcinogenesis in rats

Food and Chemical Toxicology

Volumn 42, Issue 8, 2004, Pages 1339-1347

  Shih, Chun Kuang ^a,b   Chiang, Wenchang ^b   Kuo, Min Liang ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Aberrant crypt foci; ACF, aberrant crypt foci; Adlay; AOM, azoxymethane; Azoxymethane; Colon cancer; COX 2, cyclooxygenase 2; Cyclooxygenase 2; PBS, phosphate buffered saline

Indexed keywords

ANTINEOPLASTIC AGENT; AZOXYMETHANE; CARCINOGEN; COIX LACHRYMA JOBI EXTRACT; CYCLOOXYGENASE 2; HERBACEOUS AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COIX LACRYMA JOBI; COLON CARCINOGENESIS; DEATH; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; FEEDING; INJECTION; MALE; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; AZOXYMETHANE; BODY WEIGHT; CARCINOGENS; COIX; COLON; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DIET; EATING; ISOENZYMES; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344; TAIWAN;

COIX; COIX LACRYMA-JOBI;

EID: 2942655096     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2004.03.011     Document Type: Article

References (54)

1. American Institute of Nutrition Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. Journal of Nutrition. 107:1977;1340-1348
2. American Institute of Nutrition Second report of the ad hoc committee on standards for nutritional studies. Journal of Nutrition. 110:1980;1726
3. Association of Official Analytical Chemists, 1980. Official Methods of Analysis, 13th ed. AOAC, Washington, DC
4. Bamba H., Ota S., Kato A., Adachi A., Itoyama S., Matsuzaki F. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. International Journal of Cancer. 83:1999;470-475
5. Beaty M.M., Lee E.Y., Glauert H.P. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1, 2-dimethylhydrazine- induced colon carcinogenesis in rats fed high fat diets. Journal of Nutrition. 123:1993;144-152
6. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Letters. 37:1987;147-151
7. Bird R.P. Aberrant crypt foci system to study cancer preventive agents in the colon. Hanausek M., Walaszek Z. Tumor Marker Protocols. 1998;465-474 Humana Press, Inc, Totowa, NJ
8. Bird R.P., Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters. 112-113:2000;395-402
9. Burnstein M.J. Dietary factors related to colorectal neoplasms. Surgical Clinics of North America. 73:1993;13-29
10. Caderni G., Giannini A., Lancioni L., Luceri C., Biggeri A., Dolara P. Characterization of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. British Journal of Cancer. 71:1995;763-769
11. Cameron I.L., Hardman W.E., Heitman D.W. The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in rats. Nutrition and Cancer. 28:1997;170-176
12. Chang H.-C., Huang Y.-C., Hung W.-C. Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo. Journal of Agricultural and Food Chemistry. 51:2003;3656-3660
13. Chen W.-S., Wei S.-J., Liu J.-M., Hsiao M., Kuo-Lin J., Yang W.K. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. International Journal of Cancer. 91:2001;894-899
14. Chiang W., Cheng C.-Y., Chiang M.-T., Chung K.-T. Effects of dehulled adlay on the culture count of some microbiota and their metabolism in the gastrointestinal tract of rats. Journal of Agricultural and Food Chemistry. 48:2000;829-832
15. Chiang W., Shyu M.-L., Su J.-P., Pang V.F. Evaluation of the accessory anti-tumor effect of adlay processing food. Journal of Health Science. 2:2000;113-122
16. Church R.D., Fleshman J.W., McLeod H.L. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. British Journal of Surgery. 90:2003;1055-1057
17. Corpet D.E., Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutrition and Cancer. 43:2002;1-21
18. Dannenberg A.J., Zakim D. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Seminars in Oncology. 26:1999;499-504
19. Davis P.A., Iwahashi C.K. Whole almonds and almond fractions reduce aberrant crypt foci in a rat model of colon carcinogenesis. Cancer Letters. 165:2001;27-33
20. Dimberg J., Samuelsson A., Hugander A., Soderkvist P. Differential expression of cyclo-oxygenase 2 in human colorectal cancer. Gut. 45:1999;730-732
21. DuBois R.N., Radhika A., Reddy B.S., Entingh A.J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1996;1259-1262
22. Elder D.J.E., Baker J.A., Banu N.A., Moorghen M., Paraskeva C. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. Journal of Pathology. 198:2002;428-434
23. Elsayed A.M., Shamsuddin A.M. Neoplasms of the colon. Stinson S.F., Schuller H.M., Reznik G.K. Atlas of Tumor Pathology of the Fischer Rat. 1990;133-191 CRC Press, Inc, Boca Raton, FL
24. Exon J.H., South E.H. Effects of sphingomyelin on aberrant colonic crypt foci development, colon crypt cell proliferation and immune function in an aging rat tumor model. Food and Chemical Toxicology. 41:2003;471-476
25. Fournier D.B., Gordon G.B. COX-2 and colon cancer: potential targets for chemoprevention. Journal of Cellular Biochemistry Supplement. 34:2000;97-102
26. Fujita M., Fukui H., Kusaka T., Ueda Y., Fujimori T. Immunohistochemical expression of cyclooxygenase (COX)-2 in colorectal adenomas. Journal of Gastroenterology. 35:2000;488-490
27. Hermanek P. Pathology of colorectal cancer. Bleiberg H., Kemeny N., Rougier P., Wilke H. Colorectal Cancer: A Clinical Guide to Therapy. 2002;55-72 Martin Dunitz Ltd, London
28. Holt P.R., Mokuolu A.O., Distler P., Liu T., Reddy B.S. Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutrition and Cancer. 25:1996;129-135
29. Jenab M., Chen J.-M., Thompson L.U. Sialomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Letters. 165:2001;19-25
30. Kam P.C.A., See A.U.-L. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia. 55:2000;442-449
31. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Malone W.A., Boone C.W., Kopelovich L., Hawk E.T., Lieberman R., Lawrence J.A., Ali I., Viner J.L., Sigman C.C. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. Journal of Nutrition. 130:2000;467S-471S
32. Kuo C.-C., Shih M.-C., Kuo Y.-H., Chiang W. Antagonism of free-radical-induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells. Journal of Agricultural and Food Chemistry. 49:2001;1564-1570
33. Numata M., Yamamoto A., Moribayashi A., Yamada H. Antitumor components isolated from the Chinese herbal medicine Coix lachryma-jobi. Planta Medica. 60:1994;356-359
34. Ota S., Bamba H., Kato A., Kawamoto C., Yoshida Y., Fujiwara K. COX-2, prostanoids and colon cancer. Alimentary Pharmacology and Therapeutics. 16:2002;102-106
35. Prosky L., Asp N.G., Schmeizer T.F., DeVries J.W., Furda I. Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. Journal of the Association of Official Analytical Chemists. 71:1988;1017-1023
36. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Research. 55:1995;1464-1472
37. Rao C.V., Wang C.-Q., Simi B., Rodriguez J.G., Cooma I., El-Bayoumy K., Reddy B.S. Chemoprevention of colon cancer by a glutathione conjugate of 1, 4-phenylene-bis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Research. 61:2001;3647-3652
38. Reddy B.S. Colon carcinogenesis models for chemoprevention studies. Hematology/Oncology Clinics of North America. 12:1998;963-973
39. Roy H.K., Karolski W.J., Patashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. International Journal of Cancer. 92:2001;609-615
40. Sakuma K., Fujumori T., Hirabayashi K., Terano A. Cyclooxgenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. Journal of Gastroenterology. 34:1999;189-194
41. Shao J., Sheng H., Aramandla R., Pereira M.A., Lubet R.A., Hawk E., Grogan L., Kirsch I.R., Washington M.K., Beauchamp R.D., DuBois R.N. Coordinate regulation of cyclooxygenase-2 and TGF-β 1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis. 20:1999;185-191
42. Singh J., Hamid R., Reddy B.S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Research. 57:1997;3465-3470
43. Slattery M.L., Edwards S.L., Boucher K.M., Anderson K., Caan B.J. Lifestyle and colon cancer: an assessment of factors associated with risk. American Journal of Epidemiology. 150:1999;869-877
44. Swan D.K., Ford B. Chemoprevention of cancer: review of the literature. Oncology Nursing Forum. 24:1997;719-727
45. Talbot S.M., Neugut A.I. Epidemiological trends in colorectal cancer. Saltz L.B. Colorectal Cancer: Multimodality Management. 2002;23-46 Humana Press Inc, Totowa, NJ
46. Tanaka T., Shimizu M., Kohno H., Yoshitani S.-I., Tsukio Y., Murakami A., Safitri R., Takahashi D., Yamamoto K., Koshimizu K., Ohigashi H., Mori H. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sciences. 69:2001;1935-1945
47. Tanimura A. Studies on anti-tumor component in the seeds of Coix lachryma-jobi L. var. ma-yuen (Roman.) Stapf. II. The structure of coixenolide. Chemical and Pharmaceutical Bulletin. 9:1961;47-53
48. Tokuda H., Matsumoto T., Konoshima T., Kozuka M., Nishino H., Iwashima A. Inhibitory effects on Epstein-Barr virus activation and anti-tumor promoting activities of coix seed. Planta Medica. 56:1990;653-654
49. Tsukamoto T., Kozaki K.-I., Nishikawa Y., Yamamoto M., Fukami H., Inoue M., Wakabayashi K., Tatematsu M. Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]-pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Japanese Journal of Cancer Research. 90:1999;720-725
50. Ukita T., Tanimura A. Studies on the anti-tumor component in the seeds of Coix lachryma-jobi L. var. ma-yuen (Roman.) Stapf. I. Isolation and anti-tumor activity of coixenolide. Chemical and Pharmaceutical Bulletin. 9:1961;43-46
51. Wiese F.W., Thompson P.A., Warneke J., Einspahr J., Alberts D.S., Kadlubar F.F. Variation in cyclooxygenase expression levels within the colorectum. Molecular Carcinogenesis. 37:2003;25-31
52. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 18:1999;7908-7916
53. Zhang H., Sun X.-F. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. American Journal of Gastroenterology. 97:2002;1037-1041
54. Zoran D.L., Turner N.D., Taddeo S.S., Chapkin R.S., Lupton J.R. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. Journal of Nutrition. 127:1997;2217-2225